Prof Stephen Attwood

Stephen E. Attwood, MD, FRCSI, is honorary professor in health services research at Durham University in Durham, UK, and an independent consulting advisor on research in oesophageal diseases. Most recently, he was a consultant surgeon at Northumbria Healthcare in Northumberland, UK. 

Since identifying oesophageal esophagitis (EoE) and publishing the first description of the disease, Dr Attwood has spent his career caring for patients with EoE, providing minimally invasive treatment for upper gastrointestinal disorders, including endoscopy and laparoscopic surgery. He has been actively engaged in clinical trials of upper gastrointestinal diseases, including budesonide formulations for EoE; the ASPECT trial of cancer prevention in Barrett’s oesophagus; BEST3, a study of Cytosponge screening for Barrett’s oesophagus in general practices; Endobarrier, a UK study of endoscopic antiobesity therapy; the LOTUS trial (surgery vs proton pump inhibitor for reflux therapy); and EndoStim, an electrical neuromodulator of the lower oesophageal sphincter for the treatment of gastroesophageal reflux disease. The author of 200 publications, including many papers and guidelines on EoE, he is the senior author of the British Society of Gastroenterology Guideline on Therapeutic Dilatation of the Oesophagus (published in 2018) and the European Guidelines on Eosinophilic Oesophagitis (2017). 

Join Prof Stephen in Module 1 of our EoE Management course.